Institutional investors purchased a net $1.7 million shares of RGEN during the quarter ended March 2014, and now own 87.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONESTOGA CAPITAL ADVISORS LLC Bought 821.4 Thousand shares of Repligen Corp
TFS CAPITAL LLC Bought 205.4 Thousand shares of Repligen Corp